Dear Valued Healthcare Professional,
Through the acquisition of the rights to Restylane®,
Perlane®, Sculptra®, and
Dysport®, Galderma has now entered a new exciting venture
in aesthetic medicine in the U.S. and Canada. Our most recent innovations, Emervel® Classic and Emervel®
Deep, currently sold in Europe, have been submitted to the FDA and are currently
We are determined to put all our efforts in providing the best-in-class products
as well as an expanded set of exclusive services and medical training programs to
you and your patients.
In the United States, Galderma will pursue to distribute the acquired products through
the existing distribution partner, McKesson. You are invited to
continue to order products through their current account number and phone numbers.
All accounts will automatically receive a new Galderma account number and information
on the new ordering process. You and your staff will be able to order using a phone number: 1-844-GALDERM.
If you have any questions please feel free to contact McKesson Specialty or your
Galderma’s Sales Representative.
For adverse events, medical information and quality issue reports, please call:
We are looking forward to partnering with you in aesthetic and medicine as we grow
If you would like to receive Galderma Laboratories, L.P. company
and product news and information, please visit
http://www.galdermanews.com to register.